someone had their eye on BOTA's cash.
then the Anaconda deal came along. Very generous deal to buy a French company trialling a topical treatment in Argentina. Yep, Argentina. Either genuine (silly) deal, or deliberate attempt to flush out suitor.
either way, new suitor in waiting doesn't want 8 million in cash gone and a bunch of new shares on the register.
new holder/suitor moves before Anaconda deal settles
trashes deal
company forcing suitors hand
executives and board get a few shares first
shareholders get a confidential treatment order, which is not much different to what we've been getting anyhow
...or not.
Maybe, but more likely to be solely related to the Anaconda deal is my guess
ReplyDeleteMaybe, but more likely to be solely related to the Anaconda deal is my guess
ReplyDeleteI know, you're right, it's wishful thinking.
DeleteBut again, issuing a CTO for something basically irrelevant just makes the market nervous and bang there goes confidence, liquidity, price momentum etc.
Apparently relates to the May 8 10Q statement